Cerium oxide nanoparticles can scavenge reactive molecules in the eye and prevent degenerative retinal disorders in rats. The results suggest that nanoceria particles could be used to treat a variety of problems that cause blindness.
References
Klein, R., Klein, B. E. & Linton, K. L. Ophthalmology 99, 933–943 (1992).
Augood, C. A. et al. Arch. Ophthalmol. 124, 529–35 (2006).
Sanvicens, N. et al. J. Biol. Chem. 279, 39268–78 (2004).
Chang, G. Q., Hao, Y. & Wong, F. Neuron 11, 595–605 (1993).
Chen, J., Patil, S., Seal, S. & McGinnis, J. F. Nature Nanotech. 1, 142–150 (2006).
Braun, R. D., Linsenmeier, R. A. & Goldstick, T. K. Invest. Ophthalmol. Vis. Sci. 36, 542–54 (1995).
Deshpande, S., Swanand Patil, S., Kuchibhatla, S. & Seal, S. Appl. Phys. Lett. 87, 133113 (2005).
Pepperberg, D. R. Prog. Brain Res. 131, 369–81 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silva, G. Seeing the benefits of ceria. Nature Nanotech 1, 92–94 (2006). https://doi.org/10.1038/nnano.2006.111
Issue Date:
DOI: https://doi.org/10.1038/nnano.2006.111
- Springer Nature Limited
This article is cited by
-
Vitamin B2 functionalized iron oxide nanozymes for mouth ulcer healing
Science China Life Sciences (2020)
-
Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes
Nature Protocols (2018)
-
Surface modification of nanozymes
Nano Research (2017)
-
Fate of cerium dioxide nanoparticles in endothelial cells: exocytosis
Journal of Nanoparticle Research (2015)